Since GCG encodes the precursor of GLP-1, the observed reduction in GCG and other key EEC markers (CHGA, NEUROD1, PYY) in tumor tissue, combined with these external clinical data, suggests that EECs and incretin hormones may exert an anti-tumor role in colorectal carcinogenesis. Here, PYY is linked to neoplasm.